Longitudinal exploratory analysis of tumor-specific T-cell immunity and microbiome/calprotectin testing in patients with solid tumors

Longitudinal exploratory analysis of tumor-specific T-cell immunity and microbiome/calprotectin testing in patients with solid tumors - TCIMM

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON55886

Enrollment

500

Registered

2017-01-10

Start date

2018-07-24

Completion date

Unknown

Last updated

2025-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

malignant solid tumor malignant solid tumor

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: • Histologically or cytologically proven solid tumor • Age > or = 18 years • Performance score: WHO 0-2 at the time of study entry

Exclusion criteria

Exclusion criteria: Severe anemia (Hb

Design outcomes

Primary

Measure	Time frame
See Objective of the study	—

Countries

Netherlands

Contacts

Public ContactM Slingerland

Leids Universitair Medisch Centrum

m.slingerland@lumc.nl0715263464

Outcome results